MaxCyte (NASDAQ: MXCT) restores Nasdaq minimum bid-price compliance after warning
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
MaxCyte, Inc. has regained compliance with Nasdaq’s minimum bid price rule. The company previously received a notice that its common stock had closed below $1.00 per share for 30 consecutive trading days, putting its Nasdaq Global Select Market listing at risk.
Nasdaq informed MaxCyte that for 10 consecutive business days, from May 27, 2026 to June 9, 2026, the closing bid price of its common stock was at or above $1.00. As a result, MaxCyte now complies with Nasdaq Listing Rule 5450(a)(1), and Nasdaq considers the matter closed.
Positive
- Nasdaq compliance restored: MaxCyte’s stock traded at or above $1.00 for 10 consecutive business days through June 9, 2026, bringing it back into compliance with Nasdaq Listing Rule 5450(a)(1) and closing the earlier bid-price deficiency matter.
Negative
- None.
Insights
MaxCyte removes immediate Nasdaq delisting risk by restoring bid-price compliance.
MaxCyte had fallen out of compliance with Nasdaq’s minimum bid price requirement after its stock closed below $1.00 for 30 straight trading days. Such notices can ultimately lead to delisting if not remedied within allowed timeframes.
Nasdaq now confirms that MaxCyte’s shares closed at or above $1.00 for 10 consecutive business days through June 9, 2026, satisfying Listing Rule 5450(a)(1). This restores the company’s standing on the Nasdaq Global Select Market and removes the immediate procedural overhang tied to the prior deficiency notice.
Future bid-price levels will still matter for maintaining listing status over time, but this communication states that the specific compliance matter raised in March 2026 is closed.
8-K Event Classification
Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
1 item
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice or transferred its listing to a different exchange.
Key Figures
Minimum bid price threshold: $1.00 per share
Non-compliance period length: 30 consecutive trading days
Compliance restoration window: 10 consecutive business days
+1 more
4 metrics
Minimum bid price threshold
$1.00 per share
Nasdaq Listing Rule 5450(a)(1) requirement
Non-compliance period length
30 consecutive trading days
Closing bid below $1.00 triggered deficiency notice
Compliance restoration window
10 consecutive business days
Closing bid at or above $1.00 from May 27–June 9, 2026
Compliance confirmation date
June 10, 2026
Nasdaq letter confirming MaxCyte regained compliance
Key Terms
minimum bid price requirement, Nasdaq Global Select Market, Nasdaq Listing Rule 5450(a)(1), continued listing, +1 more
5 terms
minimum bid price requirement financial
"did not comply with the minimum bid price requirement for continued listing"
A minimum bid price requirement is a rule that a stock must trade above a set price for a specified period to stay listed on an exchange. It matters to investors because falling below that threshold can trigger warnings or removal from the exchange, which can cut liquidity, reduce visibility, and often lead to sharper declines in share value—think of it like a venue’s minimum dress code that, if not met, can bar a performer from the stage.
Nasdaq Global Select Market financial
"continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1)"
A Nasdaq Global Select Market listing is the highest tier of stocks on the Nasdaq exchange, reserved for companies that meet the strictest financial, reporting and governance standards. For investors, it acts like a premium quality label—signaling larger, more transparent and better-governed companies that tend to offer greater liquidity and lower perceived risk compared with lower-tier listings, making it easier to buy, sell and evaluate shares.
Nasdaq Listing Rule 5450(a)(1) regulatory
"the minimum bid price requirement for continued listing on the Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1)"
Nasdaq Listing Rule 5450(a)(1) is a continued-listing standard that sets a minimum share price companies must maintain to remain listed on the Nasdaq market—commonly a $1.00 per-share threshold. Investors care because falling below that floor can trigger a compliance review and possible delisting, which is like failing a minimum grade and losing access to the public market; delisting can reduce liquidity, visibility and the ability to raise capital.
continued listing financial
"minimum bid price requirement for continued listing on the Nasdaq Global Select Market"
When a stock receives a "continued listing," it means the exchange has decided the company’s shares will remain tradable on that market after a review or challenge, often because the company met certain requirements or corrective steps. For investors this matters because continued listing preserves liquidity and access to buy or sell the stock—think of it as a store passing an inspection so customers can keep shopping rather than being forced to close.
closing bid price financial
"the closing bid price for the Company’s common stock had fallen below $1.00 per share"
The closing bid price is the last price that a buyer was willing to pay for a security at the end of the trading day. It reflects the final visible demand for the stock — like the last offer someone makes for a used car before a yard closes — and helps investors gauge market interest, set valuations, and mark portfolios to market for that day.
FAQ
What did MaxCyte (MXCT) announce regarding its Nasdaq listing status?
MaxCyte announced it has regained compliance with Nasdaq’s minimum bid price requirement. Its common stock closed at or above $1.00 for 10 consecutive business days, so Nasdaq considers the prior bid-price deficiency matter closed.
Why was MaxCyte (MXCT) previously out of compliance with Nasdaq rules?
MaxCyte was previously notified that its stock closed below $1.00 per share for 30 consecutive trading days. This violated Nasdaq Listing Rule 5450(a)(1), which sets the minimum bid price requirement for continued listing on the Nasdaq Global Select Market.
How did MaxCyte (MXCT) regain compliance with Nasdaq Listing Rule 5450(a)(1)?
MaxCyte regained compliance after its stock’s closing bid price reached at least $1.00 per share for 10 consecutive business days from May 27, 2026 to June 9, 2026. Nasdaq’s staff confirmed this satisfied the minimum bid price rule.
Which Nasdaq market and rule apply to MaxCyte (MXCT) in this notice?
The notice relates to MaxCyte’s listing on the Nasdaq Global Select Market and its compliance with Nasdaq Listing Rule 5450(a)(1), which specifies the minimum $1.00 per share bid price standard for continued listing.